Trial Profile
Bioequivalence of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet Compared to Concomitant Administration of Telmisartan 80 mg/Amlodipine 5 mg Fixed-dose Combination Tablet and Hydrochlorothiazide 12.5 mg Tablet in Healthy Male Subjects : an Open-label, Randomised, Single-dose, Two-sequence, Four-period Replicated Crossover Study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Apr 2017
Price :
$35
*
At a glance
- Drugs Amlodipine/telmisartan/hydrochlorothiazide (Primary) ; Amlodipine/telmisartan; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 07 Aug 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 29 Apr 2014 New trial record